Correlations of the changes in bioptic findings with
echocardiographic, clinical and laboratory parameters in
patients with inflammatory cardiomyopathy

J 2016

Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy

KREJČÍ, Jan, Petr HUDE, Hana POLOCZKOVÁ, Víta ŽAMPACHOVÁ, Radka STEPANOVA et. al.

Základní údaje

Originální název

Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy

Autoři

KREJČÍ, Jan (203 Česká republika, garant, domácí), Petr HUDE (203 Česká republika, domácí), Hana POLOCZKOVÁ (203 Česká republika, domácí), Víta ŽAMPACHOVÁ (203 Česká republika, domácí), Radka STEPANOVA (203 Česká republika), Tomas FREIBERG (203 Česká republika), Eva NĚMCOVÁ (203 Česká republika) a Lenka ŠPINAROVÁ (203 Česká republika, domácí)

Vydání

Heart and Vessels, New York, Springer, 2016, 0910-8327

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.434

Kód RIV

RIV/00216224:14110/16:00089216

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1007/s00380-014-0618-0

UT WoS

000371803600017

Klíčová slova anglicky

Myocarditis; Inflammatory cardiomyopathy; Left ventricular dysfunction; Endomyocardial biopsy; Echocardiography

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 6. 11. 2017 10:49, Soňa Böhmová

Anotace

V originále

Patients with myocarditis and left ventricular (LV) dysfunction may improve after standard heart failure therapy. This improvement seems to be related to retreat of myocardial inflammation. The aim of the present study was to assess changes in clinical, echocardiographic and some laboratory parameters and to correlate them with changes in the number of inflammatory infiltrating cells in endomyocardial biopsy (EMB) samples during the 6-month follow-up, and to define predictors of LV function improvement among baseline parameters. Forty patients with biopsy-proven myocarditis and impaired LV function (LV ejection fraction-LVEF < 40 %) with heart failure symptoms a parts per thousand currency sign6 months were evaluated. Myocarditis was defined as the presence of > 14 mononuclear leukocytes/mm(2) and/or > 7 T-lymphocytes/mm(2) in the baseline EMB. The EMB, echocardiography and clinical evaluation were repeated after 6 months of standard heart failure therapy. LVEF improved on average from 25 +/- A 9 to 42 +/- A 12 % (p < 0.001); LV end-systolic volume and LV end-diastolic volume (LVEDV) decreased from 158 +/- A 61 to 111 +/- A 58 ml and from 211 +/- A 69 to 178 +/- A 63 ml (both p < 0.001). NYHA class decreased from 2.6 +/- A 0.5 to 1.6 +/- A 0.6 (p < 0.001) and NTproBNP from 2892 +/- A 3227 to 851 +/- A 1835 A mu g/ml (p < 0.001). A decrease in the number of infiltrating leukocytes (CD45+/LCA+) from 23 +/- A 15 to 13 +/- A 8 cells/mm(2) and in the number of infiltrating T lymphocytes (CD3+) from 7 +/- A 5 to 4 +/- A 3 cells/mm(2) (both p < 0.001) was observed. The decline in the number of infiltrating CD45+ cells significantly correlated with the change in LVEF (R = -0.43; p = 0.006), LVEDV (R = 0.39; p = 0.012), NYHA classification (R = 0.35; p = 0.025), and NTproBNP (R = 0.33; p = 0.045). The decrease in the number of CD3+ cells correlated with the change of systolic and diastolic diameters of the left ventricle (R = -0.33; p = 0.038 and R = -0.45; p = 0.003) and with the change in LVEDV (R = -0.43; p = 0.006). Tricuspid annular plane systolic excursion (TAPSE) (OR 0.61; p = 0.005) and early transmitral diastolic flow velocity (E wave) (OR 0.89; p = 0.002) were identified as predictors of LVEF improvement. Improvements in clinical status, LV function and NTproBNP levels correlated with decrease in the number of infiltrating inflammatory cells. TAPSE and E wave velocity were significant predictors of improvement in multivariate regression. Our observations suggest that contemporary guidelines-based therapy of heart failure is an effective treatment option in patients with recent onset biopsy-proven inflammatory cardiomyopathy.

Citovat

KREJČÍ, Jan, Petr HUDE, Hana POLOCZKOVÁ, Víta ŽAMPACHOVÁ, Radka STEPANOVA, Tomas FREIBERG, Eva NĚMCOVÁ a Lenka ŠPINAROVÁ. Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy. Heart and Vessels. New York: Springer, 2016, roč. 31, č. 3, s. 416-426. ISSN 0910-8327. Dostupné z: https://dx.doi.org/10.1007/s00380-014-0618-0.

@article{1321699,
   author = {Krejčí, Jan and Hude, Petr and Poloczková, Hana and Žampachová, Víta and Stepanova, Radka and Freiberg, Tomas and Němcová, Eva and Špinarová, Lenka},
   article_location = {New York},
   article_number = {3},
   doi = {http://dx.doi.org/10.1007/s00380-014-0618-0},
   keywords = {Myocarditis; Inflammatory cardiomyopathy; Left ventricular dysfunction; Endomyocardial biopsy; Echocardiography},
   language = {eng},
   issn = {0910-8327},
   journal = {Heart and Vessels},
   title = {Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy},
   volume = {31},
   year = {2016}
}

TY  - JOUR
ID  - 1321699
AU  - Krejčí, Jan - Hude, Petr - Poloczková, Hana - Žampachová, Víta - Stepanova, Radka - Freiberg, Tomas - Němcová, Eva - Špinarová, Lenka
PY  - 2016
TI  - Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy
JF  - Heart and Vessels
VL  - 31
IS  - 3
SP  - 416-426
EP  - 416-426
PB  - Springer
SN  - 09108327
KW  - Myocarditis
KW  - Inflammatory cardiomyopathy
KW  - Left ventricular dysfunction
KW  - Endomyocardial biopsy
KW  - Echocardiography
N2  - Patients with myocarditis and left ventricular (LV) dysfunction may improve after standard heart failure therapy. This improvement seems to be related to retreat of myocardial inflammation. The aim of the present study was to assess changes in clinical, echocardiographic and some laboratory parameters and to correlate them with changes in the number of inflammatory infiltrating cells in endomyocardial biopsy (EMB) samples during the 6-month follow-up, and to define predictors of LV function improvement among baseline parameters. Forty patients with biopsy-proven myocarditis and impaired LV function (LV ejection fraction-LVEF < 40 %) with heart failure symptoms a parts per thousand currency sign6 months were evaluated. Myocarditis was defined as the presence of > 14 mononuclear leukocytes/mm(2) and/or > 7 T-lymphocytes/mm(2) in the baseline EMB. The EMB, echocardiography and clinical evaluation were repeated after 6 months of standard heart failure therapy. LVEF improved on average from 25 +/- A 9 to 42 +/- A 12 % (p < 0.001); LV end-systolic volume and LV end-diastolic volume (LVEDV) decreased from 158 +/- A 61 to 111 +/- A 58 ml and from 211 +/- A 69 to 178 +/- A 63 ml (both p < 0.001). NYHA class decreased from 2.6 +/- A 0.5 to 1.6 +/- A 0.6 (p < 0.001) and NTproBNP from 2892 +/- A 3227 to 851 +/- A 1835 A mu g/ml (p < 0.001). A decrease in the number of infiltrating leukocytes (CD45+/LCA+) from 23 +/- A 15 to 13 +/- A 8 cells/mm(2) and in the number of infiltrating T lymphocytes (CD3+) from 7 +/- A 5 to 4 +/- A 3 cells/mm(2) (both p < 0.001) was observed. The decline in the number of infiltrating CD45+ cells significantly correlated with the change in LVEF (R = -0.43; p = 0.006), LVEDV (R = 0.39; p = 0.012), NYHA classification (R = 0.35; p = 0.025), and NTproBNP (R = 0.33; p = 0.045). The decrease in the number of CD3+ cells correlated with the change of systolic and diastolic diameters of the left ventricle (R = -0.33; p = 0.038 and R = -0.45; p = 0.003) and with the change in LVEDV (R = -0.43; p = 0.006). Tricuspid annular plane systolic excursion (TAPSE) (OR 0.61; p = 0.005) and early transmitral diastolic flow velocity (E wave) (OR 0.89; p = 0.002) were identified as predictors of LVEF improvement. Improvements in clinical status, LV function and NTproBNP levels correlated with decrease in the number of infiltrating inflammatory cells. TAPSE and E wave velocity were significant predictors of improvement in multivariate regression. Our observations suggest that contemporary guidelines-based therapy of heart failure is an effective treatment option in patients with recent onset biopsy-proven inflammatory cardiomyopathy.
ER  -

KREJČÍ, Jan, Petr HUDE, Hana POLOCZKOVÁ, Víta ŽAMPACHOVÁ, Radka STEPANOVA, Tomas FREIBERG, Eva NĚMCOVÁ a Lenka ŠPINAROVÁ. Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy. \textit{Heart and Vessels}. New York: Springer, 2016, roč.~31, č.~3, s.~416-426. ISSN~0910-8327. Dostupné z: https://dx.doi.org/10.1007/s00380-014-0618-0.

Podrobný výpis o publikaci